Phyton Biotech has successfully transferred the manufacturing process for the microbial production of Corallopyronin A (CorA), a novel anti-infective agent with the potential to address neglected tropical diseases.
Life Sciences BC announced that Phyton Biotech was included in its list of 2025 LSBC Companies to Watch as part of its 27th Annual Life Sciences BC Awards. This recognition highlights outstanding companies to take note of and watch in the life sciences and biotech sectors.
Phyton Biotech is pleased to announce a recent publication by iScience showcasing the successful application of its plant cell fermentation platform to derive an important compound.
Phyton Biotech LLC. proudly announces a significant milestone in its journey toward advancing pharmaceutical research and development.
Phyton Biotech is delighted to be attending BIO-Europe in Munich from November 6th to 8th, 2023.
Phyton Biotech to attend CPhI Europe in Barcelona from October 24-26, 2023
Phyton Biotech to attend BioJapan from October 11 to 13, 2023
Phyton Biotech will attend the SynBioBeta Conference 2023 in Oakland, California from May 23-25.
From April 19-21, Phyton Biotech will be at CPhI Japan in Tokyo to discuss its speciality fermentation capabilities with Pharmaceutical Industry representatives.
ABSTRACT for Society of Economic Botany Conference, June 4-9, 2023: Sustainable Production of Natural Substances by Plant Cell Cultivation, Gilbert Gorr, Phyton Biotech GmbH
